Stay updated on Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Sign up to get notified when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.

Latest updates to the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRecord history now includes a new revision entry v3.7.0. The prior revision v3.6.6 has been removed from the visible history.SummaryDifference0.0%

- Check36 days agoChange DetectedA new revision entry, v3.6.6, was added to the record history and the older revision v3.6.5 was removed, indicating an update to the study record.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a minor internal update to the page. This does not affect the study data or public content.SummaryDifference0.0%

- Check72 days agoChange DetectedA new revision entry (v3.6.4) was added to the record history, replacing the previous v3.6.3. This update indicates a version bump in the page's revision history.SummaryDifference0.0%

- Check93 days agoChange DetectedThe revision in the history was updated from v3.6.2 to v3.6.3. This represents a new site version rather than changes to the trial data or content.SummaryDifference0.0%

- Check100 days agoChange DetectedThe page footer now shows Revision: v3.6.2, replacing the previous v3.6.0, indicating an updated revision label for the page history.SummaryDifference0.0%

Stay in the know with updates to Dauno/Cytarabine ± Uproleselan in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dauno/Cytarabine ± Uproleselan in AML Clinical Trial page.